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ABSTRACT 
Objectives: Two hundred twenty-four human immunodeficiency 
virus (HIV) discordant couples (one HIV negative, one HIV pos- 
itive) were compared with 78 seroconcordant heterosexually 
infected couples with HIV with regard to sexually transmitted 
diseases. 
Methods: Serologic testing and cultures were used to deter- 
mine exposure of participants to sexually transmitted pathogens. 
These data were compared with HIV concordance of partners 
to investigate possible risk factors for HIV transmission. 
Results: Syphilis, chlamydia, and hepatitis B virus (HBV) 
serologies did not distinguish between concordant and dis- 
cordant couples nor did cultures for Neisseria gonorrhoeae 
and Trichomonas or Chlamydia enzyme immunoassay (EIA). 
Risk of transmission increased with positive serologies for 
herpes simplex virus (HSV)-2 (P = 0.002), cytomegalovirus 
(CMV) (P = 0.04), and Mycoplasma genitalium (P = O.Ol), but 
not with Mycoplasma fermentans or Mycoplasma penetrans. 
Cytomegalovirus was not a significant risk factor when con- 
trolled for HSV-2 status. Examination by partner status 
showed increased risk of concordance with: HSV2 positive 
serology in both partners (odds ratio [OR] = 3.14; confidence 
interval [Cl] = 1.62-6.09; P = 0.007); HSV-2 in female sec- 
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ondaty partner (OR = 2.10; Cl = 1 .I 2-3.93; P = 0.02) or the 
male primary partner (OR = 2.15; Cl = 1 .15-4.02; P = 0.017); 
M. genitalium antibody in both partners (OR = 3.44; Cl = 
1.68-7.04; P < 0.001); M. genitalium antibody in the primary 
male partner (OR = 2.51, Cl = 1.27-4.91; P = 0.008) and M. 
genitalium antibody in the secondary female partner (OR = 
2.52; Cl = 1.21-5.23; P = 0.01). 
Conclusions: These data support the role of HSV-2 in trans- 
mission of HIV and, for the first time, suggest a role for M. 
genitalium as an independent risk factor. 
Key Words: herpes simplex, HIV mycoplasma, 
seroconcordance 
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In the United States, human immunodeficiency virus 
(HIV) type 1 infection occurs most frequently among 
homosexual men and intravenous drug users. In recent 
years, HIV incidence has increased in heterosexual men 
and women who are not intravenous drug users.’ Hetero- 
sexual intercourse is not necessarily a sufficient condition 
for the transmission of HIV; an average of only 15% of 
women who are steady partners of HIV-infected men 
acquire the infection, often despite a large number of 
unprotected sexual contacts.2.3 Although a single expo- 
sure (penile-vaginal) carries a low risk, some people have 
become infected after one or only a few sexual encoun- 
ters. The data strongly implicate cofactors that increase 
the likelihood of HIV transmission. 
Among persons at risk of acquiring HIV certain sex- 
ually transmitted diseases (STDs) have been associated 
with increased risk of HIV transmission. Genital ulcera- 
tive infections, specifically syphilis, chancroid, and herpes 
simplex virus type 2 (HSV-2), have been among the most 
consistent cofactors.*-9 These diseases probably increase 
host susceptibility by disruption of mucosal barriers and 
also offer a possible means, within the ulcers, for trans- 
mission of HIV to sexual partners. Other infections, such 
as hepatitis B virus (HBV) and cytomegalovirus (CMV) 
also may play a role in increasing host susceptibility.lOJ1 
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The roles of Neisseria gonorrhoeae, Chlamydia tra- 
cbomatis, and Trichomonas vaginalis in facilitating trans- 
mission are less clear.4~12~13 Results in vitro have suggested 
that mycoplasmas can act as cofactors with HIV in the 
development of acquired immunodeficiency syndrome 
(AIDS).‘” Higher titers of antibodies to Mycoplasmapene- 
trans also have been found in HIV-infected patients com- 
pared with noninfected individuals’j However, the relation 
of mycoplasma infection to transmission is not known. 
The authors have studied serologies and cultures of 
STDs that might promote heterosexual HIV transmission 
by comparing their prevalence in concordant (both HIV 
positive) heterosexual couples with the prevalence in 
discordant (one HIV positive, one HIV negative) hetero- 
sexual couples. Demographic, behavioral, and immuno- 
logic findings from this cohort have been reported 
previously.16s17 Skurnick et al analyzed sexual activity, con- 
dom use, and drug use. l6 The durations of the concordant 
and discordant partnerships were similar (median, 7 y). 
Male primary partners in concordant couples had a 
higher median number of lifetime partners than discor- 
dant male primary partners (25 vs. 12). Reports of sexual 
contact before the index male partner was known to be 
infected showed no significant differences between 
serodiscordant and seroconcordant couples in regard to 
frequency of vaginal intercourse or condom use during 
vaginal intercourse. Before knowledge of infection, anal 
intercourse was practiced by a higher proportion of con- 
cordant couples with a male index case than discordant 
couples (40% vs. 23%). However, the majority of both 
groups never had anal intercourse. Once couples were 
aware that the male partner was infected, over 70% 
decreased the frequency of vaginal intercourse or 
abstained, among those who eventually became concor- 
dant as well as those who remained discordant. Concor- 
dant and discordant couples did differ significantly in the 
proportions that abstained, adopted condom use, or never 
used condoms (concordant: 13%, GO%, 27%, respectively, 
vs. discordant: lS%, 72%, lo%, P = 0.01). Although few 
couples engaged in anal sex after the male partner was 
known to be seropositive, the practice was reported by 
more concordant than discordant couples (11% vs. 3%, 
P = 0.04). Among couples with a female primary part- 
ner, there were no significant differences in any sexual 
behavior practiced by concordant and discordant cou- 
ples. Seventy percent of the women had used birth con- 
trol pills at some point during the couple’s relationship, 
with no significant differences between concordant and 
discordant couples. 
Denny et al found that the most important variable 
distinguishing discordant from concordant couples was 
substantially higher CDS levels in discordant couples.” In 
multivariate analysis their CDS response appeared even 
more important than viral load as a determinant of non- 
transmission and its importance was not diminished by 
adjustment for CD4 level or stage of disease. 
METHODS 
Patient Population 
Starting in 1990, discordant heterosexual HIV couples 
were enrolled for the purpose of determining HIV sero- 
conversion rates and possible cofactors thereof. Over the 
next 2 years, transmission rates were so low that a cohort 
of concordant HIV couples was enrolled for comparison 
purposes. Data were collected by trained interviewers to 
assess potential risk factors for HIV transmission. Only 
those discordant couples with sexual transmission by het- 
erosexual activities as a potential risk factor for serocon- 
version in the negative partner were enrolled. Couples 
did not have to be married, but did have to be in an ongo- 
ing sexual relationship for 6 months or longer to be con- 
sidered “stable.” Over 90% of secondary females and SO% 
of secondary males reported being monogamous over the 
preceding 6 months. The concordant couples were simi- 
larly interviewed to ensure that sexual behavior between 
partners was, as far as could be ascertained, the mecha- 
nism of HIV transmission from one partner (primary) to 
the other (secondary) partner. The extensive structured 
interview included demographic data, a detailed alcohol, 
drug, and sexual history, and a medical history. All cou- 
ples had approximately 150 mL of serum, plasma, and 
cells drawn on enrollment. Specimens were either used 
immediately or frozen at -70°C for future studies. 
Laboratory Methods 
Serum samples were analyzed for the presence of HIV 
using commercially available enzyme-linked immunosor- 
bent assay (ELISA) (Abbott Laboratories, Abbott Park, IL) 
and confirmatory Western blot (Novopath HIV-l 
Immunoblot BioRad, Hercules, CA) testing. All sera that 
were negative by Western blot were confirmed by poly- 
merase chain reaction (PCR). Sera were sent for deter- 
mination of HSV-1 and HSV-2 type specific antibodies 
using a well-established immunoblot assay with type-spe- 
cific glycoproteins gpl and gp2.l’ Sera for CMV were 
tested by enzyme immunoassay (EL4) (Abbott Laborato- 
ries) for IgM and IgG antibodies. Syphilis testing was car- 
ried out by commercial rapid plasma reagin (RPR) test 
and a confirmatory fluorescent treponemal antibody 
absorption (FTA-ABS). Hepatitis B virus testing was done 
by determining HBsAg, anti-HBc, and HBsAb using an EIA. 
Mycoplasma serology for Mycoplasma genitalium, 
Mycoplasma fermentans, and M.penetrans was carried 
out by Dr. Shyh-Ching Lo (Armed Forces Institute of 
Pathology) using mycoplasma lipid-associated membrane 
proteins @AMPS). The ELISA techniques of studying anti- 
bodies to LAMPS in human serum samples have been 
described previously in detaiLI Neisseria gonorrhoeae 
cultures were conducted with Thayer-Martin medium in 
CO, incubators; T. vaginalis was cultured in Diamond’s 
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medium (Remel Lab, Lenexa, KS); C. trachomatis antigen 
was detected by EIA, using a commercial kit (Syva); and 
C, trachomatis serology was done by microimmunoflu- 
orescent testing. In all cases serologic results were 
reported as either positive or negative without titers. 
Statistical Analysis 
The primary endpoint was HIV concordance, as a retro- 
spective marker of transmission. The prevalence of pos- 
itive serologies in HIV-concordant partners was compared 
to the prevalence of positive serologies in HIVdiscordant 
partners. Comparisons of partners also were stratified by 
gender and index (as the primary or secondary partner). 
Comparisons of couples were stratified by the gender of 
the primary partner. Single-factor prevalence comparisons 
were performed using Fisher’s exact test; stratified exact 
tests were performed across strata. Categoric linear 
models, including logistic regression, were used for 
multivariate comparisons of HIV-concordant and HIV- 
discordant couples, to test for the joint effects of positive 
serology of one or both partners on one or moire selected 
STDs. Wilcoxon’s rank sum tests were used for group 
comparisons of the number of lifetime partners and the 
frequency of vaginal intercourse. All reported P values 
are two-tailed, and tests were performed at alpha level 
0.05, using SAS and StatXact statistical packages. 
RESULTS 
Two hundred twenty-four discordant couples and 78 con- 
cordant couples were enrolled in the study over a 4-year 
period. Table 1 presents the demographic and lbehavioral 
characteristics of the couples. Only sera drawn at base- 
line were included in the analyses. 
Herpes simplex virus-2 serology was carried out on 
192 discordant couples and 74 concordant couples. 
Results are reported only when available for both part- 
ners in a couple. Seventy-nine of the 192 discordant cou- 
ples (41.2%) had both partners negative for HSV-2 
serology, and 53 (27.6%) had both partners plositive; in 
contrast, 20 of the 74 concordant partners (27.0%) were 
both negative, and 37 (50.0%) were both positive (Table 
2). These discordant and concordant couples differ in the 
proportions of both partners being HSV-2 positive, one 
partner being HSV-2 positive, and both being HSV-2 neg- 
ative (P = 0.003, by Fisher’s exact test). In univariate analy- 
ses of couples with a male primary partner ‘(Table 3), 
HSV-2 positivity of the man was predictive of HIV con- 
cordance (OR= 2.15;CI = 1.15-4.02;P = O.O17).The same 
association with HIV-concordance was seen when only 
the female partner was HSV-2 positive (OR = 2.10; CI = 
1.12-3.93; P = 0.02). Positivity of both partners for HSV-2 
was a strong predictor of HIV-concordance (OR = 3.14; 
CI = 1.62-6.09; P = 0.007). The self-reported history of 
Table 1. Characteristics of Partners in HIV-Serodiscordant 
and HIV-Seroconcordant Couples 
HIV-Discordant HIV-Concordant 
Male Female Ma/e Female 

















Primary partner* (n) 172 52 57 11 
Source of infection in primary partner n (%) 
Personal IDU 125 (73) 1 a (35) 
Sex between men 6 (3) 
Heterosexual contact 27 (16) 24j46) 
Other 14 (8) 10 (19) 
Clinical status of primary partner + n (%) 
CDC stage A 97 (61)* 26 (50) 
B la(ii) 8 (15) 








21 (36) 3 (30) 
12 (21) 4 (40) 








*Primary partner is first partner of the couple to be infected. Index is unknown 
for 10 concordant couples. 
iMedical history is insufficient for classification of 13 discordant primary men 
and one primary concordant woman. 
*Concordant primary pattners have more advanced stage of disease than 
discordant primary partners (trend test, P = 0.008). 
IDU = injection drug use 
past herpes infections was not helpful in predicting, or 
correlating with, the HSV-2 serologies (data not shown). 
Cytomegalovirus serology was performed in 183 dis- 
cordant couples and 74 concordant couples. Among dis- 
cordant couples, 107 (58.5%) had both partners positive 
for CMV, and in 30 (16.4%), both were negative. The con- 
cordant couples showed a corresponding 73% dual pos- 
itivity and 8% negativity (see Table 2). Human 
immunodeficiency virus concordance was correlated 
with CMV positivity in both partners (P = 0.04). Among 
couples with a male primary partner, concordant cou- 
ples were more likely to be CMV IgG positive than dis- 
cordant couples (76% vs. 59%) (OR = 2.16; CI = 
1.06-4.40; P < 0.05). However, after adjustment for HSV-2 
status, CMV antibody differences between concordants 
and discordants disappeared. 
Syphilis testing by RPR was carried out in 202 dis- 
cordant and 67 concordant couples. The overall preva- 
lence of RPR positivity was 42 individuals (10.3%) in the 
discordant couples and 11 individuals (8.2%) of the con- 
cordant partners (see Table 2). These small differences 
were not statistically significant. 
Hepatitis B serology was determined in 139 discor- 
dant couples and 56 concordant couples. Positive results 
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Table 2. Sexually Transmitted Disease Serologies of Couples by HIV Concordance and Primary Partner 
HIV-Discordant HIV-Concordant 
Primary Primary 
Male n (%) Female n (%) Male n (%) Female n (%) Unknown n (%) 
HSV-2 Serology 
Number of Couples 145 47 53 11 
Both HSV2+ 34 (23) 19 (40) 26 (49) 7 (64) 4’& 
Male HSV2+/Female HSVZ- 20 (14) 1 (2) 4 (8) 0 1 (‘0) 
Male HSV2-/Female HSV2+ 26 (18) 13 (28) 6Ul) 4 (36) 2 (20) 
Both HSV2- 65 (45) 14 (30) 17 (32) 0 3 (30) 
CMV: IgG Test 
Number of Couples 133 50 
Both IgG+ 79 (59) 28 (56) 
41;;6) 6;:O) IO 
7 (70) 
Male IgG+/Female IgG- ‘2 (9) 1 (2) 2 (4) 1 (‘0) -/Fe ale IgG+ 20 (15) 13 (26) 6W) 3 (3 ) 2 :20, 
Both IgG- 22 (17) 8 (16) 5 (9) 0 1 (‘0) 
Syphilis: RPR Test 
Number of Couples 154 48 24;4) 10 9 
Both RPR+ 2 (1) 1 (2) 
Male RPR+/Female RPR- 22 (14) 2 (4) 2 (4) 1 (?O, 101;1, 
Male RPR-/Female RPR+ 5 (3) 7 (‘5) 3 (6) Both  125 (81) 38 79) 41 (85) 9 ;o, 8 ;89, 
Hepatitis B 
Number of Couples 108 6& 74136) 7 Both HBV+ 20 (19) 0 1717, 
Male HBV+/Female HBV- 52 (48) 2 (6) 23 (53) 0 Male HBV-/Female HBV+ 8 (7) 6 (‘9) 4 (9) 5 (71) $7) 
Both HBV- 28 (26) 17 (55) 9 (21) 2 (29) 4 (67) 
Mycoplasma genitahm 
Number of Couples 132 38 
Both positive 28 (21) 11 (29) 16& &l) 1$;7, 
Male+/Female- 22 (71) 3 (8) 6 (‘8) 1 (‘7) 
Male-/Female+ 35 (27) 7 (18) 6 (‘8) 2 
p29, 
1 (‘7) 
Both negative 47 (36) 17 (45) 5 (‘5) 0 3 (50) 
were interpreted as any positive tests for hepatitis B 
(HBsAg, HBcAb, or HBsAb). The seroprevalence of hepati- 
tis B was higher (54.5%) in the concordant cohort com- 
pared to the discordant (43.1%) (see Table 2). Personal 
injection drug use (IDU) was reported by 72% of con- 
cordant and 73% of discordant male index partners; 
among female primary partners, 73% of those in con- 
cordant couples and 35% in discordant couples reported 
IDU. Because of the small number of female primary part- 
ners, particularly among concordant couples, that statis- 
tically nonsignificant difference would be unlikely to 
influence observed differences. By eligibility criteria, sec- 
ondary partners necessarily had no history of IDU. Injec- 
tion drug use was an adjustment factor for analysis of 
hepatitis B prevalence because hepatitis B is transmitted 
intravenously as well as sexually The apparent differences 
in hepatitis B serology disappeared when adjusted for 
intravenous drug use of the primary partner. 
Studies of Trichomonas, gonorrhea, and Chlamy- 
dia infections by culture and antigen detection resulted 
in only a small number of positives in each group. Both 
discordant and concordant couples showed a high sero- 
prevalence of antibodies to Chlamydia; no differences 
were detected between concordant and discordant 
partners. 
Mycoplasma assays for M. genitalium, M. fermen- 
tans, and M.penetrans were performed on 453 (75%) of 
the study participants; the distribution of HIV discordant 
and HIV concordant couples was representative of the 
full cohort. Positive serology for M. genitalium was more 
common among members of HIV-concordant couples. 
Concordant and discordant couples with male primary 
partners were compared on the serology of both the man 
and woman for 165 couples with results available on 
both partners. Both partners had positive serology in 48% 
of concordant couples and both were negative in 15%, 
whereas among HIV-discordant couples, 21% were both 
positive for M. genitalium and 36% were both negative 
(P = 0.01, for difference in proportion by joint serology, 
see Table 2). Considering couples with a male primary 
partner, simultaneous M. genitalium positivity in both 
the male and female partner was strongly associated with 
HIV concordance (OR = 3.44; CI = 1.68-7.04; P = 0.001). 
Association with HIV concordance also held when M. 
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Table 3. HSV-2 and M. genifahm Positivity as Risk Factors for 
HIV-Concordance among Couples with a Male Primary Partner 





Male only M. genitalium+ 
Female only M. genifa/ium+ 
Both M. genifa/ium+ 
2.15 1.15-4.02 0.017 
2.10 1.12-3.93 0.020 
3.14 1.62-6.09 0.007 
2.51 1.27-4.9.1 0.008 
2.52 1.21-5.23 0.013 
3.44 1.68-7.04 0.001 
Logistic Regressions (n = 121) 
Model 1* 
Both HSV-2+ 3.85 1.90-7.78 0.0002 
Stage of disease in male* 1.80 1.24-2.60 0.002 
Model 2+ 
Both M. genital/urn+ 3.06 1.43-6.53 0.004 
Stage of disease in male* 1.62 1.09-2.42 0.018 
Model 3 (joint) 
Both HSV-2+ 3.03 1.31-6.99 0.009 
Both M. genitalium+ 2.13 0.94-4.83 0.071 
Stage of disease in male* 1.96 1.27-3.03 0.002 
*Stepwise including HSV-2+ serologies and stage. 
+Stepwise including M. genita/ium+ serologies and stage. 
*Odds for concordance multiplied by OR for shift to next stage of disease. 
genitalium serostatus of the primary male partner and 
secondary female partner were analyzed as separate fac- 
tors (see Table 3). 
Overall prevalence of positive serology for M. fer- 
mentans and M. penetrans was low. There were no 
observed differences by gender, HIV serostatus, or index. 
Stage of HIV disease has been a risk factor in other 
transmission studies.2-5 Table 3 takes into account the 
stage of disease (asymptomatic, symptomatic, or AIDS) 
in separate logistic models for both HSV-2 and M. geni- 
talium. In multivariate logistic regression, after adjust- 
ment for stage of disease the odds ratio was greater than 
3 for HSV-2 (OR = 3.85; CI = 1.90-7.78; P = 0.0002) or 
M. genitalium (OR = 3.06; CI = 1.43-6.53; P = 0.004) 
positivity in both partners as a risk factor for concor- 
dance. A model with all three variables indicated that 
HSV-2 serostatus of both partners was the strongest risk 
factor for HIV concordance. The odds ratio for M. geni- 
talium was approximately 2, at borderline statistical sig- 
nificance (see Table 3). Viewed together these models 
suggest that HSV-2 and M. genitalium are risk factors for 
HIV concordance independent of stage of disease and 
each other. 
Both anal sex and the greater number of lifetime part- 
ners could have played a role in the greater prevalence 
of HSV-2 and M. genitalium antibody positivity in con- 
cordant couples. To examine possible confounding of 
practice of anal sex, the couples were stratified into those 
who never had anal sex and those who had some his- 
tory of anal sex with each other. Among couples who 
never had anal sex, the odds ratio for association of HIV 
concordance and male infection with M. genitalium was 
2.24; the odds ratio for association of female infection 
with M. genitalium and concordance was 2.22. The odds 
ratios were higher among couples who had a history of 
anal sex, but not significantly so: 2.80 and 5.60. After 
adjustment for history of anal sex, the summary odds 
ratio for association of HIV concordance and male infec- 
tion with M. genitalium was 2.40 (95% CI = 1.34-4.33); 
for female infection with M. genitalium and concordance, 
the odds ratio was 2.91 (95% CI = 1.56-5.58). 
Similar analyses for association of HIV concordance 
and infection with HSV-2 also indicated a significant cor- 
relation, even after adjustment for history of anal sex. 
Among couples who never had anal sex, the odds ratio 
for association of HIV concordance and male infection 
with HSV-2 was 1.89; the odds ratio for association of 
female infection with HSV-2 and concordance was 2.30. 
These were not significantly different from the odds ratios 
among couples who had a history of anal sex (2.24 for 
male infection with HSV-2 and 1.64 for female infection 
with HSV-2). After adjustment for history of anal sex, the 
summary odds ratio for the association of HIV concor- 
dance and male infection with HSV-2 was 2.00 (95% CI: 
1.16-3.47); for female infection with HSV-2 and concor- 
dance the odds ratio was 2.01 (95% CI = 1.17-3.52). 
The variability in male partners’ number of lifetime 
sexual partners was large, and there was no evidence 
that this factor confounded the relationship between cou- 
ples’ HIV concordance and positivity for M. genitalium 
or HSV-2. 
DISCUSSION 
Many studies have suggested the risk for HIV acquisition 
or transmission is modified by STDS.~-~ Some studies have 
depended mainly on self-reported data for documenta- 
tion of STDs. This type of reporting particularly under- 
reports HSV-2 infection. 2o If clinically apparent genital 
ulcers facilitate HIV transmission, then even if the relative 
risk of HSV-2 is less than the risk associated with other 
ulcerative conditions, the absolute risk is the highest 
because of the high prevalence of HSV-2 and its frequent 
recurrences.*O Long-term prospective studies in homo- 
sexual men and case-control studies in homosexual men 
or heterosexual men and women indicate that individu- 
als with HSV-2 infection are more likely to acquire HIV 
than those without HSV-2 antibodies.5,9 At the molecular 
virologic level, it has been found that: (1) HIV RNA of 
the infectious type can be detected in genital herpetic 
ulcers in high frequency (Corey L. Private communica- 
tion); (2) reactivation of genital herpes increases HIV viral 
load’l; and (3) co-infection of human CD4 cells with HSV 
and HIV results in unidirectional accelerated replication 
of HIVz2 
Couples with both partners HSV-2 positive were 
nearly twice as likely (41.2%) to be concordant as cou- 
ples with one or neither partner positive (21%). Joint pos- 
itivity for HSV-2 was a significant predictor of HIV 
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concordance in a logistic regression model (P = 0.0002). 
One difficulty in interpretation lies in the potential tim- 
ing of infection. It is possible that HIV infection facili- 
tated the transmission of HSV-2, since HSV-2 shedding in 
HIV-positive patients is significantly higher.23 If this were 
the case however, equal transmission should have been 
evident in discordant and concordant couples with an 
HSV-2-positive male primary; this was not the case. It is 
possible that HIV infection in the secondary partner pre- 
disposes that partner to infection with HSV-2, which 
would lead to a higher prevalence in both concordant 
partners, compared with discordant partners. 
The potential role of HSV, in either acquisition or 
transmission of HIV has been ascribed primarily to its 
ability to produce clinically apparent genital ulcers. Since 
two-thirds of HSV-2 positivity rates are not associated 
with clinical disease,*O it may be that relative risk is more 
markedly increased by HSV-2 ulcerative disease but that 
the attributable risk for HSV-2 may be greater for clinically 
inapparent disease. 
The results of the M. genitalium serologic studies are 
intriguing. This organism has not been implicated as a risk 
factor for transmission or for progression of established 
HIV disease. Far too little is known about prevalence of 
antibody to M. genital&m in the general population or 
about its pathogenic potential, but serologic studies indi- 
cate that the majority of infections in humans with M. 
genitalium are clinically silent.15 The organism appears to 
be present in the urogenital tract of both male and female 
patients.** In animal experiments, infections of the male 
urethra and female genital organs with M. genitalium 
result in a substantial inflammatory response.25 Studies 
using DNA probes, PCR techniques, or serologic analyses 
suggest some cases of male nongonococcal urethritis may 
be attributable to M. gerdtalium, as may some cases of 
salpingitis. 15,24,26,27 The organism was found by PCR assay 
in blood samples from one patient with AIDS,28 M. geni- 
talium also has been detected on urethral swabs of 
patients with HIV infection.29 
Studies of antibody prevalence done by micro- 
immunofluorescence or metabolic inhibition indicate a 
low prevalence in control populations (range, 0.4-20%). 
In the present study, Mycoplasma lipid-associated mem- 
branes were used as antigens (LAMPS). Once purified, 
this group of surface proteins can be used as antigens in 
ELISA systems to detect antibodies to several different 
species of mycoplasmas. l9 Using this technique, 5.5% of 
HIV-negative healthy blood donors were found to have 
anti-M. genitalium antibodies. In contrast, 42.5% of HIV- 
negative patients attending STD clinics, 32.3% of those 
with asymptomatic HIV infection, and 44% of those with 
AIDS were seropositive.30,31 
In the present study concordant couples showed the 
highest prevalence of antibodies of any group studied to 
date, and M. genitalium infection in either sexual partner, 
and particularly in both partners, appeared to be a 
significant predictor of HIV concordance, even after 
adjustment for stage of disease. 
This study has some inherent methodologic weak- 
nesses. It was cross-sectional and retrospective. The cross- 
sectional design clearly limits the evaluation of the role of 
readily treatable infections such as nigonorrhoeae, C. tra- 
chomatis, and 1: vaginalis. These infections may have 
been present in the past, including when HIV was 
acquired. The concordant group was recruited 2 years 
after the discordant enrollment was started. No attempt 
was made to match, except on the likelihood of hetero- 
sexual transmission. By the very nature of the study, there 
were two selection biases: first, the cohort was self- 
selected; second, discordants had to have remained dis- 
cordant at least for many months and, almost always, for 
years, to be considered eligible for inclusion. Duration of 
infection also could not be used as a variable in the analy- 
sis. These unavoidable methodologic weaknesses mandate 
caution in regard to conclusions. But the study also has 
major strengths, including the number of heterosexual 
couples studied, their distribution in regard to various 
demographic variables, and the thoroughness of the study 
that permitted gathering large amounts of data for analysis. 
As recently reported, treatment and prevention of 
STDs will reduce HIV transmission.32-34 Before more for- 
malized screening and treatment recommendations can 
be properly formulated, the potential role of M. genital- 
ium will have to be investigated further and careful con- 
sideration will have to be given to more vigorous 
screening for nonulcerative infection with HSV-2. 
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